AbCellera Biologics Inc

ABCL10 Dec 2024
Healthcare
$3.03
+0.01 (+0.64%)
Lowest Today
$3
Highest Today
$3.09
Today’s Open
$3.03
Prev. Close
$3
52 Week High
$6.06
52 Week Low
$2.34
To Invest in AbCellera Biologics Inc

AbCellera Biologics Inc

Healthcare
ABCL10 Dec 2024
+0.01 (+0.64%)
1M
3M
6M
1Y
5Y
Low
$3
Day’s Range
High
$3.08
3
52 Week Low
$2.34
52-Week Range
52 Week High
$6.06
2.34
1 Day
-
1 Week
-1.31%
1 month return
+11.11%
3 month return
+25%
6 month return
-14.65%
1 Year return
-38.46%
3 Years return
-80.17%
5 Years return
-
10 Years return
-
Institutional Holdings
Baker Bros Advisors LP
9.32
Baillie Gifford & Co Limited.
4.37
ING Investment Management LLC
3.6
Prosight Management, LP
3.07
Allianz Global Artfcl Intlgc W EUR
2.07
Baillie Gifford Positive Change B Acc
1.62
Baillie Gifford Positive Change
1.61

Market Status

Fundamentals
Market Cap
886.1 mln
PB Ratio
0.82
PE Ratio
0
Enterprise Value
314.36 mln
Total Assets
1488.09 mln
Volume

Company Financials

Fund house & investment objective

Company Information
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Organisation
AbCellera Biologics Inc
Employees
586
Industry
Biotechnology
CEO
Dr. Carl L.G. Hansen Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities